期刊文献+

高危型HPV-DNA检测在宫颈癌筛查中的临床研究 被引量:1

A clinical research on high-risk HPV-DNA testing in screening of cervical disease
原文传递
导出
摘要 目的:分析基层医院中使用高危型HPV检测筛查宫颈癌的可行性,探索一种经济、实用、合理的筛查方案。方法:回顾性分析2009年7月-2010年08月间,在台州市第一人民医院妇产科行宫颈疾病筛查的患者,其中行液基薄层细胞学检查(Thinprep cytological test,TCT)的患者12 858例,行高危型HPV DNA检测的患者11 982例(二代杂交捕获法,hybrid capture-,HC-),TCT初筛与HPV分流(即TCT阳性则行HC-检测,HC-同时阳性则行阴道镜活检)。并最终以阴道镜下活检病理诊断为金标准。分析不同筛查方案诊断宫颈上皮内瘤样变(CervicalIntraepithelial Neoplasia,CIN)的灵敏度、特异度、阳性预测值、阴性预测值,以受试者工作特征曲线(ROC)下面积分析不同筛查方案。结果:TCT、HPV及TCT+HPV最终检出CIN的灵敏度、特异度、阳性预测值、阴性预测值分别为:65.7%、97.0%、58.5%;99.3%、83.5%、99.3%;71.2%、14.7%、69.9%;99.3.%、99.9%、98.8%。HPV阳性,TCT阴性患者共1 557例,接受活检者618例,阳性者109例,阳性率17.6%,发现≥CIN2病变者39例,阳性率6.3%。经ROC分析,HPV检测筛查方法明显优于TCT初筛及TCT初筛+HPV分流法(P=0.004,P=0.002)。结论:第二代杂交捕获技术(HC-)高危型HPV检测是本地区宫颈癌初次筛查的首选方法。 Objective To analyze the feasibility of high-risk HPV testing in screening of cervical cancer in primary hospital,finally explore an economical,practical,rational screening program.Methods There were 12,858 cases which received TCT,11,982 cases received high-risk HPV DNA testing,all patients received TCT screening with HPV triage(positive TCT received HPV test,both positive received colposcopy biopsy).Eventually we took colposcopic biopsy diagnosis as the gold standard,analyzed the sensitivity,specificity,positive predictive value,and negative predictive value of different screening programs for the diagnosis of CIN.Furthermore,we used ROC to analyze efficiency of different screening programs.Results Final sensitivity,specificity,positive predictive value,negative predictive value for TCT,HPV and TCT + HPV in detection of CIN were 65.7%,97.0%,58.5%;99.3%,83.5%,99.3%;71.2%,14.7%,69.9%;and 99.3%,99.9%,98.8%,respectively.Furthermore,there were 1557 cases with HPV-positive,TCT-negative.Among them,618 cases received biopsy,and 109 cases found suffering with CIN(17.6%),and CIN2 lesions were found in 39 cases(6.3%).ROC analysis demonstrated that HPV testing was superior to TCT or TCT + HPV screening method(P=0.004,P=0.002).Conclusion High-risk HPV testing is the prior method for screening of cervical cancer in this region.
出处 《中国农村卫生事业管理》 2011年第11期1180-1182,共3页 Chinese Rural Health Service Administration
关键词 宫颈上皮内瘤样病变 液基薄层细胞学检查(TCT) 第二代杂交捕获技术(HC-Ⅱ) 高危型HPV 筛查方法 cervical intraepithelial lesion ThinPrep cytology(TCT) second-generation hybrid capture(HC-Ⅱ) high-risk HPV screening
  • 相关文献

参考文献8

  • 1赵方辉,章文华,潘秦镜,张询,陈汶,刘彬,马俊飞,胡尚英,乔友林.宫颈癌多种筛查方案的研究[J].中华肿瘤杂志,2010,32(6):420-424. 被引量:71
  • 2Cuzlek J, Clavel C, Petty KU,et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening [J]. Int J Cancer. 2006:119:1095-1101.
  • 3Cuzick J ,Arbyn M ,Sankaranarayanan R,et al. Overview of Human Papillomavirus- Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries [J]. Vaccine, 2008,26 Suppl 10:K29-41.
  • 4Kulasingam SL, Rajan R, St Pierre Y, et al. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a costeffectiveness analysis [J]. BMC Med,2009,9(7):69.
  • 5Soren K, Kharbanda EO, Chen S, et al. A 6 - year experience with Pap smears in an urban adolescent practice: the scope and burden of abnormalities[J]. J Pediatr Adolesc Gynecol, 2009,22 (4) : 217-22.
  • 6Torres Lobat6n A,Rojo Herrera G,Torres Rojo A,et al. Cervical cancer. Current view of its epidemiology and risk factors[J]. Ginecol Obstet Mex. 2004:72:466-74.
  • 7Sellors JW, Karwalajtys TL, Kaczorowski JA, et al. Prevalence of infection with carcinogenic human papitlomavirus among older women [J]. CMAJ. 2002;167 (8):871-3.
  • 8Kyndi M, Frederiksen K, Krtiger Kjaer S. Cervical cancer .ncidence in Denmark over six decades (1943-2002)[J]. Aeta Obstet Gynecol Scand, 2006,85 ( 1 ) :106-11.

二级参考文献22

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Gravitt P,Coutlee F,Iftner T,et al.New technologies in cervical cancer screening.Vaccine,2008,26 Suppl 10:K42-52.
  • 3Anttila A,Pukkala E,S(o)dennan B,et al.Effect of organized screening on cervical cancer incidence and mortality in Finland,1963-1995; recent increase in cervical cancer incidence.Int J Cancer,1999,83:59-65.
  • 4Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shanxi Province Cervical Cancer Screening Study.Int J Gynecol Cancer,1999,9:411-417.
  • 5Belinson J,Qiao YL,Pretorius R,et al.Shanxi Province Cervical Cancer Screening Study; a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.Gynecol Oncol,2001,83:439-444.
  • 6Arbyn M,Sasieni P,Meijer CJ,et al.Chapter 9:Clinical applications of HPV testing:a summary of meta-analyses.Vaccine,2006,24 Suppl 3:S3/78-89.
  • 7Moss S,Gray A,Legood R,et al.Effect of testing for human papillomavirus as a triage during screening for cervical cancer:observational before and after study.BMJ,2006,332:83-85.
  • 8Cuzick J,Szarewski A,Mesher D,et al.Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology:results from the Hammersmith study.Int J Cancer,2008,122:2294-2300.
  • 9Shi JF,Belinson JL,Zhao FH,et al.Human papillomavirus testing for cervical cancer screening:results from a 6-year prospective study in rural China.Am J Epidemiol,2009,170:708-716.
  • 10Goldie SJ,Gaffikin L,Goldhaber-Fiebert JD,et al.Cost-effectiveness of cervical-cancer screening in five developing countries.N Engl J Med,2005,353:2158-2168.

共引文献70

同被引文献9

引证文献1

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部